[en] Activation-induced deaminase (AID) mediates the somatic hypermutation (SHM) of Ig variable (V) regions that is required for the affinity maturation of the antibody response. An intensive analysis of a published database of somatic hypermutations that arose in the IGHV3-23*01 human V region expressed in vivo by human memory B cells revealed that the focus of mutations in complementary determining region (CDR)1 and CDR2 coincided with a combination of overlapping AGCT hotspots, the absence of AID cold spots, and an abundance of polymerase eta hotspots. If the overlapping hotspots in the CDR1 or CDR2 did not undergo mutation, the frequency of mutations throughout the V region was reduced. To model this result, we examined the mutation of the human IGHV3-23*01 biochemically and in the endogenous heavy chain locus of Ramos B cells. Deep sequencing revealed that IGHV3-23*01 in Ramos cells accumulates AID-induced mutations primarily in the AGCT in CDR2, which was also the most frequent site of mutation in vivo. Replacing the overlapping hotspots in CDR1 and CDR2 with neutral or cold motifs resulted in a reduction in mutations within the modified motifs and, to some degree, throughout the V region. In addition, some of the overlapping hotspots in the CDRs were at sites in which replacement mutations could change the structure of the CDR loops. Our analysis suggests that the local sequence environment of the V region, and especially of the CDR1 and CDR2, is highly evolved to recruit mutations to key residues in the CDRs of the IgV region.
Disciplines :
Genetics & genetic processes
Author, co-author :
Wei, Lirong; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461
CHAHWAN, Richard ; University of Luxembourg > Faculty of Science, Technology and Medicine (FSTM) > Department of Health, Medicine and Life Sciences (DHML) ; Department of Biosciences, University of Exeter, Exeter EX2 4QD, United Kingdom
Wang, Shanzhi; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461
Wang, Xiaohua; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461
Pham, Phuong T; Department of Biological Sciences and Department of Chemistry, University of Southern California, Los Angeles, CA 90089
Goodman, Myron F; Department of Biological Sciences and Department of Chemistry, University of Southern California, Los Angeles, CA 90089
Bergman, Aviv; Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY 10461, and
Scharff, Matthew D; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, matthew.scharff@einstein.yu.edu thomas.maccarthy@stonybrook.edu
MacCarthy, Thomas; Department of Applied Mathematics and Statistics, State University of New York, Stony Brook, NY 11794 matthew.scharff@einstein.yu.edu thomas.maccarthy@stonybrook.edu
External co-authors :
yes
Language :
English
Title :
Overlapping hotspots in CDRs are critical sites for V region diversification.
Publication date :
17 February 2015
Journal title :
Proceedings of the National Academy of Sciences of the United States of America
West AP, Jr, et al. (2014) Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156(4):633-648.
Keim C, Kazadi D, Rothschild G, Basu U (2013) Regulation of AID, the B-cell genome mutator. Genes Dev 27(1):1-17.
Rogozin IB, Diaz M (2004) Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. J Immunol 172(6):3382-3384.
Zhang W, et al. (2001) Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int Immunol 13(9):1175-1184.
Golding GB, Gearhart PJ, Glickman BW (1987) Patterns of somatic mutations in immunoglobulin variable genes. Genetics 115(1):169-176.
Jolly CJ, et al. (1996) The targeting of somatic hypermutation. Semin Immunol 8(3): 159-168.
Di Noia J, Neuberger MS (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419(6902):43-48.
Di Noia JM, Neuberger MS (2007) Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 76:1-22.
Stavnezer J, et al. (2014) Differential expression of APE1 and APE2 in germinal centers promotes error-prone repair and A:T mutations during somatic hypermutation. Proc Natl Acad Sci USA 111(25):9217-9222.
Peled JU, et al. (2008) The biochemistry of somatic hypermutation. Annu Rev Immunol 26:481-511.
Bransteitter R, Pham P, Scharff MD, Goodman MF (2003) Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc Natl Acad Sci USA 100(7):4102-4107.
Peters A, Storb U (1996) Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4(1):57-65.
Sun J, Rothschild G, Pefanis E, Basu U (2013) Transcriptional stalling in B-lymphocytes: A mechanism for antibody diversification and maintenance of genomic integrity. Transcription 4(3):127-135.
Nambu Y, et al. (2003) Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302(5653):2137-2140.
Pavri R, et al. (2010) Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143(1):122-133.
Willmann KL, et al. (2012) A role for the RNA pol II-associated PAF complex in AIDinduced immune diversification. J Exp Med 209(11):2099-2111.
Jeevan-Raj BP, et al. (2011) Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination. J Exp Med 208(8):1649-1660.
Michael N, et al. (2003) The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19(2):235-242.
Orthwein A, Di Noia JM (2012) Activation induced deaminase: How much and where? Semin Immunol 24(4):246-254.
Woo CJ, Martin A, Scharff MD (2003) Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin. Immunity 19(4):479-489.
Kodgire P, Mukkawar P, North JA, Poirier MG, Storb U (2012) Nucleosome stability dramatically impacts the targeting of somatic hypermutation. Mol Cell Biol 32(10): 2030-2040.
Wang L, Wuerffel R, Feldman S, Khamlichi AA, Kenter AL (2009) S region sequence, RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination. J Exp Med 206(8):1817-1830.
Faili A, et al. (2002) AID-dependent somatic hypermutation occurs as a DNA singlestrand event in the BL2 cell line. Nat Immunol 3(9):815-821.
Gitlin AD, Shulman Z, Nussenzweig MC (2014) Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509(7502):637-640.
Rouaud P, et al. (2013) The IgH 3′ regulatory region controls somatic hypermutation in germinal center B cells. J Exp Med 210(8):1501-1507.
Buerstedde JM, Alinikula J, Arakawa H, McDonald JJ, Schatz DG (2014) Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences. PLoS Biol 12(4):e1001831.
Liu M, et al. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature 451(7180):841-845.
Yamane A, et al. (2011) Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol 12(1): 62-69.
Pappas L, et al. (2014) Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516(7531):418-422.
Wang F, et al. (2013) Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation. Proc Natl Acad Sci USA 110(11):4261-4266.
Zheng NY, Wilson K, Jared M, Wilson PC (2005) Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation. J Exp Med 201(9):1467-1478.
Shapiro GS, Aviszus K, Murphy J, Wysocki LJ (2002) Evolution of Ig DNA sequence to target specific base positions within codons for somatic hypermutation. J Immunol 168(5):2302-2306.
Yu K, Huang FT, Lieber MR (2004) DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J Biol Chem 279(8): 6496-6500.
Zarrin AA, et al. (2004) An evolutionarily conserved target motif for immunoglobulin class-switch recombination. Nat Immunol 5(12):1275-1281.
Tashiro J, Kinoshita K, Honjo T (2001) Palindromic but not G-rich sequences are targets of class switch recombination. Int Immunol 13(4):495-505.
Han L, Masani S, Yu K (2011) Overlapping activation-induced cytidine deaminase hotspot motifs in Ig class-switch recombination. Proc Natl Acad Sci USA 108(28): 11584-11589.
Zhang ZZ, et al. (2014) The strength of an Ig switch region is determined by its ability to drive R loop formation and its number of WGCW sites. Cell Reports 8(2):557-569.
Matsuda F, et al. (1998) The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 188(11):2151-2162.
Barbas SM, et al. (1995) Human autoantibody recognition of DNA. Proc Natl Acad Sci USA 92(7):2529-2533.
Brezinschek HP, Brezinschek RI, Lipsky PE (1995) Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 155(1):190-202.
Jiang N, et al. (2013) Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 5(171):171ra119.
Dal-Bo M, et al. (2011) B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage. Br J Haematol 153(1):3-14.
Ohm-Laursen L, Nielsen M, Larsen SR, Barington T (2006) No evidence for the use of DIR, D-D fusions, chromosome 15 open reading frames or VH replacement in the peripheral repertoire was found on application of an improved algorithm, Joint ML, to 6329 human immunoglobulin H rearrangements. Immunology 119(2):265-277.
Ohm-Laursen L, Barington T (2007) Analysis of 6912 unselected somatic hypermutations in human VDJ rearrangements reveals lack of strand specificity and correlation between phase II substitution rates and distance to the nearest 3′ activation-induced cytidine deaminase target. J Immunol 178(7):4322-4334.
Chahwan R, Edelmann W, Scharff MD, Roa S (2012) AIDing antibody diversity by error-prone mismatch repair. Semin Immunol 24(4):293-300.
North B, Lehmann A, Dunbrack RL, Jr (2011) A new clustering of antibody CDR loop conformations. J Mol Biol 406(2):228-256.
Wu TT, Kabat EA (1970) An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 132(2):211-250.
Spencer J, Dunn-Walters DK (2005) Hypermutation at A-T base pairs: The A nucleotide replacement spectrum is affected by adjacent nucleotides and there is no reverse complementarity of sequences flanking mutated A and T nucleotides. J Immunol 175(8):5170-5177.
Zivojnovic M, et al. (2014) Somatic hypermutation at A/T-rich oligonucleotide substrates shows different strand polarities in Ung-deficient or -proficient backgrounds. Mol Cell Biol 34(12):2176-2187.
Zhao Y, et al. (2013) Mechanism of somatic hypermutation at the WA motif by human DNA polymerase η. Proc Natl Acad Sci USA 110(20):8146-8151.
Storb U, Shen HM, Nicolae D (2009) Somatic hypermutation: Processivity of the cytosine deaminase AID and error-free repair of the resulting uracils. Cell Cycle 8(19): 3097-3101.
McKean D, et al. (1984) Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci USA 81(10): 3180-3184.
Jacob J, Przylepa J, Miller C, Kelsoe G (1993) In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J Exp Med 178(4):1293-1307.
Pham P, Calabrese P, Park SJ, Goodman MF (2011) Analysis of a single-stranded DNAscanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversity. J Biol Chem 286(28):24931-24942.
Mak CH, Pham P, Afif SA, Goodman MF (2013) A mathematical model for scanning and catalysis on single-stranded DNA, illustrated with activation-induced deoxycytidine deaminase. J Biol Chem 288(41):29786-29795.
Baughn LB, et al. (2011) Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells. MBio 2(5):e00186-11.
Sale JE, Neuberger MS (1998) TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 9(6): 859-869.
Kano C, Wang JY (2013) High levels of AID cause strand bias of mutations at A versus T in Burkitt's lymphoma cells. Mol Immunol 54(3-4):397-402.
Weiser AA, et al. (2011) Affinity maturation of B cells involves not only a few but a whole spectrum of relevant mutations. Int Immunol 23(5):345-356.
Kehoe JM, Capra JD (1971) Localization of two additional hypervariable regions in immunoglobulin heavy chains. Proc Natl Acad Sci USA 68(9):2019-2021.
Wilson TM, et al. (2005) MSH2-MSH6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes. J Exp Med 201(4):637-645.
Ranjit S, et al. (2011) AID recruits UNG and Msh2 to Ig switch regions dependent upon the AID C terminus [corrected]. J Immunol 187(5):2464-2475.
Li Z, et al. (2006) The mismatch repair protein Msh6 influences the in vivo AID targeting to the Ig locus. Immunity 24(4):393-403.
Frieder D, Larijani M, Collins C, Shulman M, Martin A (2009) The concerted action of Msh2 and UNG stimulates somatic hypermutation at A. T base pairs. Mol Cell Biol 29(18):5148-5157.
Larijani M, et al. (2007) AID associates with single-stranded DNA with high affinity and a long complex half-life in a sequence-independent manner. Mol Cell Biol 27(1): 20-30.
Mu Y, Prochnow C, Pham P, Chen XS, Goodman MF (2012) A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants. J Biol Chem 287(33):28007-28016.
Larijani M, Frieder D, Basit W, Martin A (2005) The mutation spectrum of purified AID is similar to the mutability index in Ramos cells and in ung(-/-)msh2(-/-) mice. Immunogenetics 56(11):840-845.
Lingwood D, et al. (2012) Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489(7417):566-570.
Xu H, et al. (December 18, 2014) Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage. Proteins, 10.1002/prot.24745.
Schmidt AG, et al. (2013) Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci USA 110(1):264-269.
Haynes BF, Kelsoe G, Harrison SC, Kepler TB (2012) B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol 30(5):423-433.
Jardine J, et al. (2013) Rational HIV immunogen design to target specific germline B cell receptors. Science 340(6133):711-716.
MacCarthy T, et al. (2009) V-region mutation in vitro, in vivo, and in silico reveal the importance of the enzymatic properties of AID and the sequence environment. Proc Natl Acad Sci USA 106(21):8629-8634.
Maccarthy T, Roa S, Scharff MD, Bergman A (2009) SHMTool: A webserver for comparative analysis of somatic hypermutation datasets. DNA Repair (Amst) 8(1):137-141.
